[The prophylaxis of hepatocellular carcinoma by interferon-alpha in virus-induced cirrhosis].
Merle
P
P
Laboratoire de Recherche sur les Hépatites et Pathologies Associées, INSERM U 271, cours Albert-Thomas, 69424 Lyon Cedex 03, France.
Zoulim
F
F
Vitvitski
L
L
Trépo
C
C
D006528:Carcinoma, Hepatocellular / Q000517:prevention & control* / Q000821:virology*; D003043:Cocarcinogenesis; D018450:Disease Progression; D019694:Hepatitis B, Chronic / Q000150:complications* / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D019698:Hepatitis C, Chronic / Q000150:complications* / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D006801:Humans; D016898:Interferon-alpha / Q000494:pharmacology / Q000627:therapeutic use*; D008103:Liver Cirrhosis / Q000150:complications*; D008113:Liver Neoplasms / Q000517:prevention & control* / Q000821:virology*; D008115:Liver Regeneration / Q000187:drug effects; D011322:Primary Prevention / Q000379:methods*; D015398:Signal Transduction / Q000187:drug effects; D016896:Treatment Outcome
D016898:Interferon-alpha